Ginsenoside-Rd Induces Cholesterol Efflux from Macrophage-Derived Foam Cells Conjunction with Cardiovascular, Pharmacological and Biochemical Evaluations
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Download Product Insert (PDF)
Product Information U-46619 Item No. 16450 CAS Registry No.: 56985-40-1 Formal Name: 9,11-dideoxy-9α,11α-methanoepoxy-prosta- 5Z,13E-dien-1-oic acid Synonym: 9,11-dideoxy-9α,11α-methanoepoxy COOH Prostaglandin F2α MF: C21H34O4 O FW: 350.5 Purity: ≥98% OH Stability: ≥2 years at -20°C Supplied as: A solution in methyl acetate Laboratory Procedures For long term storage, we suggest that U-46619 be stored as supplied at -20°C. It will be stable for at least two years. U-46619 is supplied as a solution in methyl acetate. To change the solvent, simply evaporate the methyl acetate under a gentle stream of nitrogen and immediately add the solvent of choice. Solvents such as DMSO, ethanol, and dimethyl formamide purged with an inert gas can be used. The solubility of U-46619 in these solvents is aproximately 100 mg/ml. Further dilutions of the stock solution into aqueous buffers or isotonic saline should be made prior to performing biological experiments. Ensure that the residual amount of organic solvent is insignificant since organic solvents may have physiological effects at low concentrations. If an organic solvent-free solution of U-46619 is needed, it can be prepared by evaporating the methyl acetate and directly dissolving the neat oil in aqueous buffers. The solubility of U-46619 in PBS (pH 7.2) is approximately 2 mg/ml. We do not recommend storing the aqueous solution for more than one day. 1 U-46619 is a stable analog of the endoperoxide prostaglandin H2, and a TP receptor agonist. -
Chemical Composition and Product Quality Control of Turmeric
Stephen F. Austin State University SFA ScholarWorks Faculty Publications Agriculture 2011 Chemical composition and product quality control of turmeric (Curcuma longa L.) Shiyou Li Stephen F Austin State University, Arthur Temple College of Forestry and Agriculture, [email protected] Wei Yuan Stephen F Austin State University, Arthur Temple College of Forestry and Agriculture, [email protected] Guangrui Deng Ping Wang Stephen F Austin State University, Arthur Temple College of Forestry and Agriculture, [email protected] Peiying Yang See next page for additional authors Follow this and additional works at: http://scholarworks.sfasu.edu/agriculture_facultypubs Part of the Natural Products Chemistry and Pharmacognosy Commons, and the Pharmaceutical Preparations Commons Tell us how this article helped you. Recommended Citation Li, Shiyou; Yuan, Wei; Deng, Guangrui; Wang, Ping; Yang, Peiying; and Aggarwal, Bharat, "Chemical composition and product quality control of turmeric (Curcuma longa L.)" (2011). Faculty Publications. Paper 1. http://scholarworks.sfasu.edu/agriculture_facultypubs/1 This Article is brought to you for free and open access by the Agriculture at SFA ScholarWorks. It has been accepted for inclusion in Faculty Publications by an authorized administrator of SFA ScholarWorks. For more information, please contact [email protected]. Authors Shiyou Li, Wei Yuan, Guangrui Deng, Ping Wang, Peiying Yang, and Bharat Aggarwal This article is available at SFA ScholarWorks: http://scholarworks.sfasu.edu/agriculture_facultypubs/1 28 Pharmaceutical Crops, 2011, 2, 28-54 Open Access Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.) ,1 1 1 1 2 3 Shiyou Li* , Wei Yuan , Guangrui Deng , Ping Wang , Peiying Yang and Bharat B. Aggarwal 1National Center for Pharmaceutical Crops, Arthur Temple College of Forestry and Agriculture, Stephen F. -
(12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
US 2004O224012A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn et al. (43) Pub. Date: Nov. 11, 2004 (54) TOPICAL APPLICATION AND METHODS Related U.S. Application Data FOR ADMINISTRATION OF ACTIVE AGENTS USING LIPOSOME MACRO-BEADS (63) Continuation-in-part of application No. 10/264,205, filed on Oct. 3, 2002. (76) Inventors: Pichit Suvanprakorn, Bangkok (TH); (60) Provisional application No. 60/327,643, filed on Oct. Tanusin Ploysangam, Bangkok (TH); 5, 2001. Lerson Tanasugarn, Bangkok (TH); Suwalee Chandrkrachang, Bangkok Publication Classification (TH); Nardo Zaias, Miami Beach, FL (US) (51) Int. CI.7. A61K 9/127; A61K 9/14 (52) U.S. Cl. ............................................ 424/450; 424/489 Correspondence Address: (57) ABSTRACT Eric G. Masamori 6520 Ridgewood Drive A topical application and methods for administration of Castro Valley, CA 94.552 (US) active agents encapsulated within non-permeable macro beads to enable a wider range of delivery vehicles, to provide longer product shelf-life, to allow multiple active (21) Appl. No.: 10/864,149 agents within the composition, to allow the controlled use of the active agents, to provide protected and designable release features and to provide visual inspection for damage (22) Filed: Jun. 9, 2004 and inconsistency. US 2004/0224012 A1 Nov. 11, 2004 TOPCAL APPLICATION AND METHODS FOR 0006 Various limitations on the shelf-life and use of ADMINISTRATION OF ACTIVE AGENTS USING liposome compounds exist due to the relatively fragile LPOSOME MACRO-BEADS nature of liposomes. Major problems encountered during liposome drug Storage in vesicular Suspension are the chemi CROSS REFERENCE TO OTHER cal alterations of the lipoSome compounds, Such as phos APPLICATIONS pholipids, cholesterols, ceramides, leading to potentially toxic degradation of the products, leakage of the drug from 0001) This application claims the benefit of U.S. -
In Vitro Immunopharmacological Profiling of Ginger (Zingiber Officinale Roscoe)
Research Collection Doctoral Thesis In vitro immunopharmacological profiling of ginger (Zingiber officinale Roscoe) Author(s): Nievergelt, Andreas Publication Date: 2011 Permanent Link: https://doi.org/10.3929/ethz-a-006717482 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS. ETH Nr. 19591 In Vitro Immunopharmacological Profiling of Ginger (Zingiber officinale Roscoe) ABHANDLUNG zur Erlangung des Titels DOKTOR DER WISSENSCHAFTEN der ETH ZÜRICH vorgelegt von Andreas Nievergelt Eidg. Dipl. Apotheker, ETH Zürich geboren am 18.12.1978 von Schleitheim, SH Angenommen auf Antrag von Prof. Dr. Karl-Heinz Altmann, Referent Prof. Dr. Jürg Gertsch, Korreferent Prof. Dr. Michael Detmar, Korreferent 2011 Table of Contents Summary 6 Zusammenfassung 7 Acknowledgements 8 List of Abbreviations 9 1. Introduction 13 1.1 Ginger (Zingiber officinale) 13 1.1.1 Origin 14 1.1.2 Description 14 1.1.3 Chemical Constituents 15 1.1.4 Traditional and Modern Pharmaceutical Use of Ginger 17 1.1.5 Reported In Vitro Effects 20 1.2 Immune System and Inflammation 23 1.2.1 Innate and Adaptive Immunity 24 1.2.2 Cytokines in Inflammation 25 1.2.3 Pattern Recognition Receptors 29 1.2.4 Toll-Like Receptors 30 1.2.5 Serotonin 1A and 3 Receptors 32 1.2.6 Phospholipases A2 33 1.2.7 MAP Kinases 36 1.2.8 Fighting Inflammation, An Ongoing Task 36 1.2.9 Inflammation Assays Using Whole Blood 38 1.3 Arabinogalactan-Proteins 39 1.3.1 Origin and Biological Function of AGPs 40 1.3.2 Effects on Animals 41 1.3.3 The ‘Immunostimulation’ Theory 42 1/188 2. -
Viewer Token: Utgzgyeiftozbgp)
BASIC RESEARCH www.jasn.org A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation Maria B. Monteiro,1 Susanne Ramm,1,2 Vidya Chandrasekaran,1 Sarah A. Boswell,1 Elijah J. Weber,3 Kevin A. Lidberg,3 Edward J. Kelly,3 and Vishal S. Vaidya1,2,4 1Harvard Program in Therapeutic Science, Harvard Medical School Laboratory of Systems Pharmacology, Boston, Massachusetts; 2Renal Division, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts; 3Department of Pharmaceutics, University of Washington, Seattle, Washington; and 4Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts ABSTRACT Background The death of epithelial cells in the proximal tubules is thought to be the primary cause of AKI, but epithelial cells that survive kidney injury have a remarkable ability to proliferate. Because proximal tubular epithelial cells play a predominant role in kidney regeneration after damage, a potential approach to treat AKI is to discover regenerative therapeutics capable of stimulating proliferation of these cells. Methods We conducted a high-throughput phenotypic screen using 1902 biologically active compounds to identify new molecules that promote proliferation of primary human proximal tubular epithelial cells in vitro. Results The primary screen identified 129 compounds that stimulated tubular epithelial cell proliferation. A secondary screen against these compounds over a range of four doses confirmed that eight resulted in a significant increase in cell number and incorporation of the modified thymidine analog EdU (indicating actively proliferating cells), compared with control conditions. These eight compounds also stimulated tubular cell proliferation in vitro after damage induced by hypoxia, cadmium chloride, cyclosporin A, or polymyxin B. -
Editorial Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2018
Hindawi Oxidative Medicine and Cellular Longevity Volume 2019, Article ID 6380473, 3 pages https://doi.org/10.1155/2019/6380473 Editorial Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2018 Robert E. Smith ,1 Tomris Ozben ,2 and Luciano Saso 3 1Park University, 8700 River Park Drive, Parkville, MO 64152, USA 2Department of Biochemistry, Akdeniz University Medical Faculty Campus, Dumlupinar Street, 07070 Antalya, Turkey 3Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy Correspondence should be addressed to Robert E. Smith; [email protected] Received 5 June 2019; Accepted 9 June 2019; Published 3 July 2019 Copyright © 2019 Robert E. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Chronic, low-grade, smoldering inflammation (also called in vitro tests for total antioxidant capacity emerged. They parainflammation) can lead to cardiovascular and neurode- were based on measuring the destruction of oxidized test generative diseases, as well as many types of cancer [1]. It compounds by reacting directly with the antioxidants in can be caused by obesity, metabolic syndrome, and even foods [1, 2]. periodontal disease. One of the articles in this special issue However, as scientists and physicians learned more about tells how adding antioxidants to dental materials can help to human nutrition, they realized that the caloric restriction prevent oxidative stress in gingival fluid (“Influence of Dental that worked for other organisms did not work for humans Restorations on Oxidative Stress in Gingival Crevicular [1, 2]. -
Anthocyanins and Intestinal Barrier Function: a Review
Journal of International Society for Food Bioactives Nutraceuticals and Functional Foods Review J. Food Bioact. 2019;5:18–30 Anthocyanins and intestinal barrier function: a review Jonathan C. Valdez and Bradley W. Bolling* Department of Food Science, University of Wisconsin-Madison, 1605 Linden Dr., Madison, WI 53706, USA *Corresponding author: Bradley W Bolling, 1605 Linden Dr. Madison, WI 53706, USA. Tel: 608-890-0212; E-mail: [email protected] DOI: 10.31665/JFB.2019.5175 Received: December 15, 2018; Revised received & accepted: December 31, 2018 Citation: Valdez, J.C, and Bolling, B.W (2019). Anthocyanins and intestinal barrier function: a review. J. Food Bioact. 5: 18–30. Abstract Chronic intestinal inflammation, occurring in inflammatory bowel diseases (IBD), is associated with compromised intestinal barrier function. Inflammatory cytokines disrupt tight junctions and increase paracellular permeability of luminal antigens. Thus, chronic intestinal barrier dysfunction hinders the resolution of inflammation. Dietary approaches may help mitigate intestinal barrier dysfunction and chronic inflammation. A growing body of work in rodent models of colitis has demonstrated that berry consumption inhibits chronic intestinal inflammation.- Ber ries are a rich dietary source of polyphenolic compounds, particularly anthocyanins. However, berry anthocyanins have limited bioavailability and are extensively metabolized by the gut microbiota and host tissue. This review summarizes the literature regarding the beneficial functions of anthocyanin-rich berries in treating and prevent- ing IBD. Here, we will establish the role of barrier function in the pathogenesis of IBD and how dietary anthocya- nins and their known microbial catabolites modulate intestinal barrier function. Keywords: Colitis; Barrier function; Anthocyanin; Metabolism; Inflammatory Bowel Diseases. -
Long-Term Sodium Ferulate Supplementation Scavenges Oxygen Radicals and Reverses Liver Damage Induced by Iron Overloading
molecules Article Long-Term Sodium Ferulate Supplementation Scavenges Oxygen Radicals and Reverses Liver Damage Induced by Iron Overloading Yang Qiao 1,†, Huan He 2,†, Zeyu Zhang 2, Zhangping Liao 2, Dong Yin 3, Dan Liu 2,*, Bo Yi 4,* and Ming He 1,* 1 Jiangxi Provincial Institute of Hypertension, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China; [email protected] 2 Jiangxi Provincial Key Laboratory of Basic Pharmacology, Nanchang University School of Pharmaceutical Science, Nanchang 330006, China; [email protected] (H.H.); [email protected] (Z.Z.); [email protected] (Z.L.) 3 Jiangxi Provincial Key Laboratory of Molecular Medicine at the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China; [email protected] 4 Second Abdominal Surgery Department, Jiangxi Province Tumor Hospital, Nanchang 330029, China * Correspondence: [email protected] (D.L.); [email protected] (B.Y.); [email protected] (M.H.); Tel.: +86-185-0791-5527 (D.L.); +86-135-1700-7527 (B.Y.); +86-791-8636-2231 (M.H.) † These authors contributed equally to this work. Academic Editor: Derek J. McPhee Received: 12 August 2016; Accepted: 8 September 2016; Published: 16 September 2016 Abstract: Ferulic acid is a polyphenolic compound contained in various types of fruits and wheat bran. As a salt of the active ingredient, sodium ferulate (SF) has potent free radical scavenging activity and can effectively scavenge ROS. In this study, we examined the effect of SF on iron-overloaded mice in comparison to a standard antioxidant, taurine (TAU). We determined the protective role of SF against liver injury by examining liver-to-body ratio (%), transaminase and hepatocyte apoptosis in rats supplied with 10% dextrose intraperitoneal injection. -
Acetylcholine Signaling System in Progression of Lung Cancers
Pharmacology & Therapeutics 194 (2019) 222–254 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Acetylcholine signaling system in progression of lung cancers Jamie R. Friedman a,1, Stephen D. Richbart a,1,JustinC.Merritta,KathleenC.Browna, Nicholas A. Nolan a, Austin T. Akers a, Jamie K. Lau b, Zachary R. Robateau a, Sarah L. Miles a,PiyaliDasguptaa,⁎ a Department of Biomedical Sciences, Joan C. Edwards School of Medicine, 1700 Third Avenue, Huntington, WV 25755 b Biology Department, Center for the Sciences, Box 6931, Radford University, Radford, Virginia 24142 article info abstract Available online 3 October 2018 The neurotransmitter acetylcholine (ACh) acts as an autocrine growth factor for human lung cancer. Several lines of evidence show that lung cancer cells express all of the proteins required for the uptake of choline (choline Keywords: transporter 1, choline transporter-like proteins) synthesis of ACh (choline acetyltransferase, carnitine acetyl- Lung cancer transferase), transport of ACh (vesicular acetylcholine transport, OCTs, OCTNs) and degradation of ACh (acetyl- Acetylcholine cholinesterase, butyrylcholinesterase). The released ACh binds back to nicotinic (nAChRs) and muscarinic Cholinergic receptors on lung cancer cells to accelerate their proliferation, migration and invasion. Out of all components Proliferation of the cholinergic pathway, the nAChR-signaling has been studied the most intensely. The reason for this trend Invasion Anti-cancer drugs is due to genome-wide data studies showing that nicotinic receptor subtypes are involved in lung cancer risk, the relationship between cigarette smoke and lung cancer risk as well as the rising popularity of electronic ciga- rettes considered by many as a “safe” alternative to smoking. -
NINDS Custom Collection II
ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC -
Imaging Functional Brain Connectivity
Imaging Functional Brain Connectivity: pharmacological modulation, aging & Alzheimer’s disease Bernadet L. Klaassens 1 Table of contents Chapter 1 3 Introduction and aims Part I: Pharmacological challenge effects on brain connectivity in healthy young adults Chapter 2 10 Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity (NeuroImage 2015 Nov; 122: 440-450) Chapter 3 31 Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation (Human Brain Mapping 2017 Jan; 38 (1): 308-325) Part II: Functional brain connectivity and neuromodulation in older age and Alzheimer’s disease Chapter 4 60 Diminished posterior precuneus connectivity with the default mode network differentiates normal aging from Alzheimer’s disease (Frontiers in Aging Neuroscience 2017 Apr; 9: 1-13) Chapter 5 84 Serotonergic and cholinergic modulation of functional brain connectivity: a comparison between young and older adults ( NeuroImage 2018 Apr; 169: 312-322) Chapter 6 108 Imaging cholinergic and serotonergic neurotransmitter networks in Alzheimer’s disease in vivo (Submission at Alzheimer’s and Dementia) Chapter 7 131 Summary and general discussion 2 Chapter 1 Introduction and aims Brain function relies heavily on neural communication and connections. Better understanding of the mechanisms that are related to maintenance or deterioration of brain function requires a technique that takes into account the elaborate nature of the central nervous system (CNS). A useful method for that purpose is to assess the brain’s functional connectivity. Brain regions are functionally connected to each other when they exhibit correlating activation patterns (Friston et al., 1993), illustrating the complex organization of neural networks. Interactions between regions and within networks largely depend on chemical transmission between neurons. -
Role of Proaggregatory and Antiaggregatory Prostaglandins in Hemostasis
Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. P Gresele, … , G Pieters, J Vermylen J Clin Invest. 1987;80(5):1435-1445. https://doi.org/10.1172/JCI113223. Research Article Thromboxane synthase inhibition can lead to two opposing effects: accumulation of proaggregatory cyclic endoperoxides and increased formation of antiaggregatory PGI2 and PGD2. The elimination of the effects of the cyclic endoperoxides by an endoperoxide-thromboxane A2 receptor antagonist should enhance the inhibition of hemostasis by thromboxane synthase blockers. We have carried out a series of double-blind, placebo-controlled, crossover studies in healthy volunteers to check if this hypothesis may be operative in vivo in man. In a first study, in 10 healthy male volunteers, the combined administration of the thromboxane receptor antagonist BM 13.177 and the thromboxane synthase inhibitor dazoxiben gave stronger inhibition of platelet aggregation and prolonged the bleeding time more than either drug alone. In a second study, in 10 different healthy male volunteers, complete inhibition of cyclooxygenase with indomethacin reduced the prolongation of the bleeding time by the combination BM 13.177 plus dazoxiben. In a third study, in five volunteers, selective cumulative inhibition of platelet TXA2 synthesis by low-dose aspirin inhibited platelet aggregation and prolonged the bleeding time less than the combination BM 13.177 plus dazoxiben. In vitro, in